O'Callaghan M. Re: Addition of Nintedanib or Placebo to Neoadjuvant Gemcitabine and Cisplatin in
Locally Advanced Muscle-invasive Bladder Cancer (NEOBLADE): A Double-blind,
Randomised, Phase 2 Trial. Eur Urol 2023 Jun 9:S0302-2838(23)02871-3. doi: 10.1016/j.eururo.2023.
PMID: 37302943
![]() |
![]() |
![]() |